Pataday is an FDA-approved OTC antihistamine eye drop made by Alcon, containing olopatadine hydrochloride as its active compound. It is designed for adults and children 2 and older dealing with itchy, red, or watery eyes from seasonal or year-round allergic conjunctivitis. No prescription is required at any US pharmacy.
Olopatadine blocks H1 histamine receptors and stabilizes mast cells, stopping the allergic cascade at two separate points. Relief starts within 3 to 5 minutes of application. The Once Daily formula provides up to 16 hours of coverage per dose. Physician approval on Sermo sits at 98%, confirming strong real-world prescriber confidence in performance.
This review covers how Pataday works, what real users say about it, how it compares to Zaditor and LASTACAFT, what side effects to watch for, and whether the price is justified for uninsured buyers. All the key facts needed to make a confident purchase decision are covered here in full.
What Are Pataday Eye Drops?
Pataday Eye Drops are an FDA-approved OTC antihistamine eye drop containing olopatadine hydrochloride, clinically proven to relieve itching from allergic conjunctivitis. Here’s the thing: they work directly in the eye, targeting the source of allergy symptoms without the drowsiness that oral antihistamines often bring.
Alcon originally offered olopatadine exclusively by prescription under the brand name Patanol. The shift to OTC status expanded access for millions of allergy sufferers who previously needed a doctor visit just to get relief. That’s a significant change for anyone dealing with seasonal eye symptoms every year.
The drops are approved for adults and children 2 years and older who experience itchy, red, or watery eyes from seasonal or year-round eye allergies. No prescription is required at any US pharmacy or major retailer.
What Ingredients Are in Pataday Eye Drops?
Olopatadine hydrochloride is the sole active ingredient in Pataday, with concentrations of 0.1%, 0.2%, and 0.7% depending on the specific formulation purchased. In plain English: the higher the concentration, the stronger the dose and the fewer times you need to apply it per day.
Benzalkonium chloride (BAK) serves as the preservative in all Pataday formulations. Here’s what that means for contact lens wearers: BAK absorbs into soft lens material and may irritate sensitive eyes with long-term use, which is why the label requires lens removal before instillation.
Inactive ingredients include sodium chloride, sodium phosphate dibasic, hydrochloric acid, sodium hydroxide for pH adjustment, and purified water. These components create the buffered solution that keeps the eye comfortable during and after application.
What Versions of Pataday Are Available?
Alcon’s Pataday lineup includes three distinct formulations: Once Daily Relief (0.2%), Twice Daily Relief (0.1%), and Extra Strength Once Daily Relief (0.7%), each serving a different severity level of eye allergy symptoms. The choice between them depends on symptom frequency and intensity.
Pataday Once Daily Relief at 0.2% olopatadine is the most widely purchased formulation. One drop provides up to 16 hours of allergy relief. That makes Once Daily the practical choice for most allergy sufferers who want long-lasting control without mid-day redosing.
Extra Strength Pataday at 0.7% olopatadine is the highest OTC concentration available. Alcon positioned it specifically for patients with more persistent or severe allergic conjunctivitis who find standard concentrations insufficient for full-day symptom management. In fact, it’s the strongest OTC eye allergy drop on the market right now.
Pataday Formulation Comparison:
| Product | Olopatadine % | Dosing Frequency | Duration |
| Pataday Twice Daily Relief | 0.1% | Twice daily | ~8 hours |
| Pataday Once Daily Relief | 0.2% | Once daily | Up to 16 hours |
| Pataday Extra Strength | 0.7% | Once daily | Up to 16 hours |
How Do Pataday Eye Drops Work?
Olopatadine operates through a dual mechanism, functioning simultaneously as a selective H1 histamine receptor antagonist and as a mast cell stabilizer, blocking the allergic cascade at two separate points. This dual action is what sets it apart from older, single-mechanism eye drops.
The H1 receptor blockade addresses the immediate allergic response. By binding to H1 receptors in the conjunctiva, olopatadine prevents histamine from triggering itch signals and blood vessel dilation. Think of it this way: oral antihistamines use the same mechanism, but Pataday applies it directly to the affected tissue for faster results.
And here’s the better part. The mast cell stabilizing action addresses the root cause. Olopatadine prevents mast cells from releasing histamine in the first place. The result is both immediate symptom control and a sustained preventive layer that continues working throughout the dosing interval.
How Quickly Does Pataday Relieve Eye Allergy Symptoms?
Pataday begins relieving allergy-driven eye itching within 3 to 5 minutes of application, with peak antihistamine effect in the conjunctiva reached within 30 minutes of instillation. Clinical measurement tools confirm the rapid reduction in itching scores even at that early time point.
The good news? The Once Daily and Extra Strength formulations maintain therapeutic olopatadine levels in ocular tissue for up to 16 hours after a single dose. A morning application delivers coverage throughout the full waking day without requiring a second dose.
Topical olopatadine outpaces oral antihistamines on speed of onset. Oral options such as cetirizine or fexofenadine require 30 to 60 minutes for systemic absorption and distribution before eye symptoms improve. Pataday’s direct delivery to the conjunctiva bypasses the digestive tract entirely, meaning faster local action and no systemic sedation.
What Are the Benefits of Pataday Eye Drops?
Pataday Eye Drops address all four hallmark symptoms of allergic conjunctivitis in a single daily dose: ocular itching, redness, tearing, and eyelid swelling. That makes Pataday a comprehensive option for allergy eye care. No oral supplement or separate eye rinse is needed alongside it for standard allergy management.
The OTC availability removes a major barrier to access. Previously prescription-only under the Patanol brand, Pataday is now sold at pharmacies nationwide without a doctor visit. This change saves patients the cost and time of a medical appointment for routine seasonal eye allergy management. That’s real money back in people’s pockets.
The non-drowsy profile is a practical advantage over systemic options. Unlike diphenhydramine or even cetirizine, topical olopatadine produces negligible systemic absorption. Users report no drowsiness, dry mouth, or cognitive impairment. The formula is fully compatible with driving, work, and daily activities.
Main Benefits:
- Relieves ocular itching within 3 to 5 minutes of application
- Controls redness and tearing from allergic conjunctivitis
- Once-daily dosing eliminates mid-day reapplication
- No drowsiness or dry mouth unlike oral antihistamines
- Available OTC at any major pharmacy
Does Pataday Once Daily Relief Actually Work?
Yes. Pataday Once Daily Relief (0.2%) significantly reduces ocular itching scores versus vehicle placebo at the p less than 0.001 significance level within 3 minutes of application in multiple randomized controlled trials. The clinical evidence for its efficacy is among the strongest in the OTC eye allergy category.
Pataday holds a 98% approval rating on the Sermo physician drug ratings platform. That’s not a marketing claim. It’s near-universal endorsement from ophthalmologists and allergists who have both prescribed and observed results in real patients, reflecting strong prescriber confidence in the product’s real-world performance.
Adherence data further validates the once-daily formulation. Studies on ophthalmic drop adherence consistently show once-daily regimens achieve meaningfully higher compliance rates than twice-daily or more frequent schedules, directly translating to better therapeutic outcomes for actual patients.
Does Extra Strength Pataday Work Better?
Extra Strength Pataday (0.7%) was found statistically non-inferior to the 0.2% formulation in head-to-head trials, offering equivalent efficacy at a higher concentration for patients who need breakthrough relief from persistent symptoms. It’s not uniformly superior, but it fills a genuine clinical gap.
The higher concentration targets patients with more severe or persistent allergic conjunctivitis. Pharmacists recommend it for individuals who still experience significant itching by midday on the standard dose. So what does that mean for you? Start with Once Daily. Step up only if needed.
The cost difference is a practical consideration. Extra Strength Pataday carries a higher price point than Once Daily Relief. The standard clinical recommendation is to try the 0.2% formulation first and step up to Extra Strength only when standard-dose control proves insufficient.
How Do You Use Pataday Eye Drops?
The standard Pataday instillation technique requires tilting the head back, pulling the lower eyelid downward to create a pocket, dropping one drop into that pocket, then gently closing the eye for 1 to 2 minutes to allow full ocular absorption. The closed-eye step is critical for maximizing bioavailability in the conjunctiva.
Contact lens handling is a mandatory precaution. Soft lenses must be removed before applying Pataday because the preservative benzalkonium chloride absorbs into lens material. After instillation, a 10-minute wait is required before reinserting lenses to prevent lens discoloration and ocular irritation. Don’t skip this step.
Bottle hygiene prevents contamination of the solution. The dropper tip must not touch the eye surface, eyelid, or any external object. The cap should be replaced immediately after each use to maintain sterility throughout the bottle’s shelf life.
What Is the Correct Pataday Dosage?
Pataday dosing varies by formulation: Once Daily and Extra Strength require 1 drop per affected eye once daily, while Twice Daily Relief requires 1 drop per affected eye twice daily, spaced approximately 6 to 8 hours apart. The schedule is determined by the specific product purchased.
Pataday is approved for children 2 years and older at the same adult dose of 1 drop per application. No pediatric dose reduction is needed because systemic absorption from ophthalmic drops is minimal, limiting exposure to the rest of the body regardless of patient size.
Missed doses follow a straightforward protocol. A forgotten dose should be applied as soon as it’s remembered on the same day. If the next scheduled dose is approaching, the missed dose is skipped entirely. Doubling up on drops to compensate for a missed dose is not recommended.
How to Apply Pataday Correctly:
- Wash hands thoroughly before handling the bottle.
- Remove contact lenses if wearing them.
- Tilt head back and pull the lower eyelid down to form a pocket.
- Instill 1 drop into the lower eyelid pocket without touching the dropper tip to the eye.
- Close the eye gently for 1 to 2 minutes to allow absorption.
- Wait 10 minutes before reinserting contact lenses.
- Cap the bottle immediately after use.
What Do Pataday Eye Drops Reviews Say?
Pataday Eye Drops consistently earn 4.5 to 4.8 out of 5 stars across major pharmacy and retail platforms, with the majority of reviewers citing fast relief and convenient once-daily dosing as the product’s standout strengths. The volume and consistency of positive feedback across platforms reflects a genuinely high-performing product.
Thousands of verified purchaser reviews exist across Amazon, CVS, Walgreens, and WebMD. That pool of real-world performance data is statistically meaningful and diverse. The review base spans multiple years and multiple allergy seasons, giving strong confidence in the consistency of results.
Physician feedback reinforces the consumer data. The 98% physician recommendation rate on Sermo reflects consistent clinical experience with reliable patient outcomes. That’s a level of prescriber endorsement that few OTC eye care products ever achieve.
What Do Users Like About Pataday?
Positive reviewers most frequently praise how quickly Pataday relieves itching, with many reporting noticeable improvement within minutes of the first application, often describing the relief as near-immediate compared to other drops they’d tried. Speed is the defining strength users return to in review after review.
Once-daily dosing ranks as the second most praised feature across platforms. Reviewers specifically mention no longer needing to carry drops to work or reapply mid-afternoon, describing the once-daily schedule as a quality-of-life improvement over older twice-daily products they’d used previously.
Users switching from oral antihistamines consistently praise the absence of drowsiness and dry mouth. The ability to manage eye allergy symptoms without systemic sedation allows daily use before driving and during work. Bottom line: it works without the baggage.
What Complaints Do Pataday Users Have?
Negative reviewers most commonly report a brief stinging or burning sensation immediately upon application, a side effect noted by approximately 10 to 15 percent of users across review platforms, typically resolving within 60 seconds of instillation. Most users describe the sensation as tolerable given the relief that follows.
Price is the second most common complaint. Uninsured users frequently note that a 2.5 mL bottle costs $18 to $22 (USD) at retail, which translates to a meaningful monthly expense, particularly for bilateral users who go through the small bottle faster. Budget-conscious reviewers point to generic olopatadine as a cost-saving alternative.
Temporary blurred vision affects a subset of users for 1 to 2 minutes post-instillation. Reviewers familiar with this effect advise applying the drops at least 2 to 3 minutes before needing clear vision, such as before driving or using a computer, to avoid the brief visual disruption.
Pros:
- Fast-acting relief within 3 to 5 minutes
- Once-daily dosing for maximum convenience
- No drowsiness or systemic side effects
- 98% physician approval rating
- Available OTC at any major pharmacy
Cons:
- Brief stinging on application for some users
- Higher price than competing ketotifen drops
- Small 2.5 mL bottle size limits bilateral supply duration
- Contains BAK preservative, unsuitable for long-term use in sensitive eyes
How Does Pataday Compare to Zaditor and LASTACAFT?
The OTC allergy eye drop market is led by Pataday (olopatadine), Zaditor (ketotifen fumarate), and Alaway (ketotifen fumarate), while LASTACAFT (alcaftadine 0.25%) remains prescription-only in most markets and targets a different clinical segment. Each product occupies a distinct position on efficacy, dosing, and price.
The active ingredient difference matters pharmacologically. Pataday uses olopatadine HCl while Zaditor and Alaway use ketotifen fumarate. Both are second-generation antihistamines with mast cell stabilizing properties. Olopatadine has a longer peer-reviewed clinical history in allergic conjunctivitis, with more published trials available.
Pricing creates a clear market divide. Zaditor typically retails at $12 to $16 (USD) for a 5 mL bottle compared to Pataday Once Daily at $18 to $22 (USD) for 2.5 mL. Zaditor offers more volume per dollar, but its twice-daily dosing requirement means more applications per day and lower real-world compliance rates.
Pataday vs Zaditor vs LASTACAFT Comparison:
| Product | Active Ingredient | Dosing | OTC/Rx | Price (USD) |
| Pataday Once Daily | Olopatadine 0.2% | Once daily | OTC | $18-$22 |
| Zaditor | Ketotifen 0.035% | Twice daily | OTC | $12-$16 |
| Alaway | Ketotifen 0.035% | Twice daily | OTC | $11-$15 |
| LASTACAFT | Alcaftadine 0.25% | Once daily | Rx only | Varies |
Is Pataday Better Than Zaditor?
Head-to-head data shows both olopatadine and ketotifen provide clinically significant relief from allergic conjunctivitis, but olopatadine 0.2% demonstrated marginally superior duration of action in several published comparative trials, supporting Pataday’s once-daily dosing claim. Neither drug has proven categorically superior for all patients.
Pataday’s once-daily schedule outperforms Zaditor’s twice-daily requirement on adherence metrics. Compliance studies show once-daily regimens achieve higher adherence than twice-daily ones. And here’s what that actually means: better adherence translates to better sustained allergy control in practice.
Cost-per-day analysis narrows the price gap between the two. Zaditor costs approximately $0.07 to $0.09 (USD) per drop at bilateral dosing while Pataday runs $0.14 to $0.18. Pataday requires fewer drops per day, partially offsetting its higher per-drop cost.
What Are the Side Effects of Pataday Eye Drops?
Pataday’s most common adverse reactions include transient burning or stinging upon instillation, headache, eye dryness, and brief blurred vision, reported in 1 to 5 percent of patients in clinical trials and typically resolving without treatment within minutes. The short-lived nature of these effects is the reason most users rate tolerance as high.
Rare but serious adverse reactions require immediate attention. Severe eye pain, significant vision changes, markedly increased redness, or unusual discharge may signal a corneal reaction or secondary infection. Any of these effects warrants stopping use and contacting a healthcare provider. Don’t wait it out.
Benzalkonium chloride, the preservative in Pataday, carries a long-term concern. BAK can accumulate on the corneal epithelium with prolonged daily use. Preservative-free olopatadine formulations exist for patients with chronic dry eye who need BAK-free options.
Common Side Effects:
- Transient burning or stinging upon instillation
- Brief blurred vision (1 to 2 minutes post-application)
- Headache
- Eye dryness
- Mild eyelid swelling in rare cases
Who Should Avoid Using Pataday Eye Drops?
Patients with known hypersensitivity to olopatadine hydrochloride or benzalkonium chloride should not use Pataday, as allergic reactions to either component can trigger severe ocular inflammation, intense redness, and corneal damage requiring medical treatment. A prior reaction to either ingredient is an absolute contraindication.
Patients with a diagnosed bacterial or viral eye infection should not substitute Pataday for appropriate antimicrobial or antiviral treatment. Pataday addresses allergic conjunctivitis specifically. Using it for an infectious condition delays evidence-based care and can allow the infection to worsen while symptoms appear superficially controlled.
Pregnant and breastfeeding patients carry an FDA Pregnancy Category C classification. Systemic absorption is minimal, but clinical safety data in pregnant populations is limited. Consultation with a healthcare provider before use during pregnancy or lactation is the standard precaution.
How Much Does Pataday Cost?
Pataday pricing ranges from approximately $15 to $18 (USD) for Twice Daily Relief, $18 to $22 (USD) for Once Daily Relief, and $20 to $26 (USD) for Extra Strength Once Daily, with variation depending on the retailer and any active promotions. All three formulations are widely available at comparable prices online and in-store.
Insurance and discount programs reduce out-of-pocket costs substantially. GoodRx and similar prescription discount platforms can lower the retail price of Pataday by 20 to 40 percent at participating pharmacies. Patients with a valid prescription from a doctor may also qualify for insurance coverage that reduces the cost to a standard copay.
Volume affects the effective daily cost more than the bottle price alone. Each 2.5 mL Pataday bottle yields approximately 80 to 85 drops. At bilateral once-daily dosing, a bottle lasts roughly 40 days. The effective cost runs approximately $0.40 to $0.60 (USD) per day.
Pataday Retail Price by Formulation:
| Formulation | Bottle Size | Typical Retail (USD) | Days Supply (bilateral) |
| Twice Daily Relief | 2.5 mL | $15-$18 | ~20 days |
| Once Daily Relief | 2.5 mL | $18-$22 | ~40 days |
| Extra Strength | 2.5 mL | $20-$26 | ~40 days |
Is Pataday Worth the Price?
Yes. Ophthalmologists and pharmacists broadly consider Pataday’s once-daily formula worth its premium over twice-daily alternatives, citing the compliance advantage and the strength of the clinical evidence as factors that justify the higher per-bottle cost for patients who need reliable daily eye allergy management.
Generic olopatadine offers the same active ingredient at significantly lower cost. Generic 0.1% and 0.2% eye drops are widely available at $8 to $12 (USD) per bottle. Pharmacists confirm the generic is bioequivalent to branded Pataday. It’s a sound option for cost-focused buyers.
The OTC transition creates net savings even at branded retail prices. Before the switch, patients paid $100 to $250 (USD) for a prescribing visit plus the drug cost. The OTC price of $18 to $22 (USD) without a doctor visit is a meaningful reduction for routine allergy care.
Where Can You Buy Pataday Eye Drops?
Pataday Eye Drops are available without a prescription at major US pharmacy chains including CVS, Walgreens, and Rite Aid, as well as mass retailers like Walmart, Target, and Costco, and online platforms including Amazon and Walmart.com. Distribution breadth ensures easy access in virtually every US market.
International buyers face more variable access. In Canada, olopatadine is marketed as PATADAY by Novartis Pharmaceuticals Canada Inc. In other markets, OTC availability differs by country; some nations still classify olopatadine as prescription-only.
Is Pataday Cheaper to Buy Online?
Online purchasing offers meaningful savings for repeat Pataday buyers, with Amazon and Walmart subscription programs reducing per-bottle cost by 5 to 15 percent compared to standard retail pricing. Amazon Prime members in major US markets can access same-day or next-day delivery.
GoodRx and similar platforms extend savings further at physical pharmacies. Discount codes available on GoodRx can reduce the retail price of Pataday by 20 to 40 percent at participating chains, bringing the price closer to generic olopatadine for insured and uninsured buyers alike.
Is Pataday Worth It?
Pataday Eye Drops are a clinically proven, FDA-approved OTC solution with a 98% physician approval rate and strong consumer ratings, representing a reliable and well-evidenced choice for adults and children managing allergy-related eye itching. The combination of clinical data and real-world feedback supports its standing as a first-line recommendation in the OTC eye allergy category.
The product delivers the best value for patients with moderate to severe allergic conjunctivitis who need fast, long-lasting relief without systemic side effects. The once-daily schedule removes an adherence barrier that undermines older twice-daily formulas in real-world use.
Should You Use Generic Olopatadine Instead?
Generic olopatadine 0.2% drops are bioequivalent to branded Pataday Once Daily and available at $8 to $12 (USD) per bottle, roughly half the branded price, making them the recommended choice for budget-focused allergy sufferers. Pharmacists confirm the same active ingredient at the same concentration delivers the same clinical result.
The branded Pataday option makes sense for buyers who want name-brand assurance or access to Extra Strength 0.7%, which has no widely available generic equivalent yet. Pataday Once Daily Relief is the best starting point. Extra Strength is there if standard control proves insufficient.